-
Automated Scoring of Nuclear Pleomorphism Spectrum with Pathologist-level Performance in Breast Cancer
Authors:
Caner Mercan,
Maschenka Balkenhol,
Roberto Salgado,
Mark Sherman,
Philippe Vielh,
Willem Vreuls,
Antonio Polonia,
Hugo M. Horlings,
Wilko Weichert,
Jodi M. Carter,
Peter Bult,
Matthias Christgen,
Carsten Denkert,
Koen van de Vijver,
Jeroen van der Laak,
Francesco Ciompi
Abstract:
Nuclear pleomorphism, defined herein as the extent of abnormalities in the overall appearance of tumor nuclei, is one of the components of the three-tiered breast cancer grading. Given that nuclear pleomorphism reflects a continuous spectrum of variation, we trained a deep neural network on a large variety of tumor regions from the collective knowledge of several pathologists, without constraining…
▽ More
Nuclear pleomorphism, defined herein as the extent of abnormalities in the overall appearance of tumor nuclei, is one of the components of the three-tiered breast cancer grading. Given that nuclear pleomorphism reflects a continuous spectrum of variation, we trained a deep neural network on a large variety of tumor regions from the collective knowledge of several pathologists, without constraining the network to the traditional three-category classification. We also motivate an additional approach in which we discuss the additional benefit of normal epithelium as baseline, following the routine clinical practice where pathologists are trained to score nuclear pleomorphism in tumor, having the normal breast epithelium for comparison. In multiple experiments, our fully-automated approach could achieve top pathologist-level performance in select regions of interest as well as at whole slide images, compared to ten and four pathologists, respectively.
△ Less
Submitted 24 December, 2020; v1 submitted 9 December, 2020;
originally announced December 2020.
-
A Pathologist-Annotated Dataset for Validating Artificial Intelligence: A Project Description and Pilot Study
Authors:
Sarah N Dudgeon,
Si Wen,
Matthew G Hanna,
Rajarsi Gupta,
Mohamed Amgad,
Manasi Sheth,
Hetal Marble,
Richard Huang,
Markus D Herrmann,
Clifford H. Szu,
Darick Tong,
Bruce Werness,
Evan Szu,
Denis Larsimont,
Anant Madabhushi,
Evangelos Hytopoulos,
Weijie Chen,
Rajendra Singh,
Steven N. Hart,
Joel Saltz,
Roberto Salgado,
Brandon D Gallas
Abstract:
Purpose: In this work, we present a collaboration to create a validation dataset of pathologist annotations for algorithms that process whole slide images (WSIs). We focus on data collection and evaluation of algorithm performance in the context of estimating the density of stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. Methods: We digitized 64 glass slides of hematoxylin- and eo…
▽ More
Purpose: In this work, we present a collaboration to create a validation dataset of pathologist annotations for algorithms that process whole slide images (WSIs). We focus on data collection and evaluation of algorithm performance in the context of estimating the density of stromal tumor infiltrating lymphocytes (sTILs) in breast cancer. Methods: We digitized 64 glass slides of hematoxylin- and eosin-stained ductal carcinoma core biopsies prepared at a single clinical site. We created training materials and workflows to crowdsource pathologist image annotations on two modes: an optical microscope and two digital platforms. The workflows collect the ROI type, a decision on whether the ROI is appropriate for estimating the density of sTILs, and if appropriate, the sTIL density value for that ROI. Results: The pilot study yielded an abundant number of cases with nominal sTIL infiltration. Furthermore, we found that the sTIL densities are correlated within a case, and there is notable pathologist variability. Consequently, we outline plans to improve our ROI and case sampling methods. We also outline statistical methods to account for ROI correlations within a case and pathologist variability when validating an algorithm. Conclusion: We have built workflows for efficient data collection and tested them in a pilot study. As we prepare for pivotal studies, we will consider what it will take for the dataset to be fit for a regulatory purpose: study size, patient population, and pathologist training and qualifications. To this end, we will elicit feedback from the FDA via the Medical Device Development Tool program and from the broader digital pathology and AI community. Ultimately, we intend to share the dataset, statistical methods, and lessons learned.
△ Less
Submitted 14 October, 2020;
originally announced October 2020.
-
Self-Supervised Nuclei Segmentation in Histopathological Images Using Attention
Authors:
Mihir Sahasrabudhe,
Stergios Christodoulidis,
Roberto Salgado,
Stefan Michiels,
Sherene Loi,
Fabrice André,
Nikos Paragios,
Maria Vakalopoulou
Abstract:
Segmentation and accurate localization of nuclei in histopathological images is a very challenging problem, with most existing approaches adopting a supervised strategy. These methods usually rely on manual annotations that require a lot of time and effort from medical experts. In this study, we present a self-supervised approach for segmentation of nuclei for whole slide histopathology images. Ou…
▽ More
Segmentation and accurate localization of nuclei in histopathological images is a very challenging problem, with most existing approaches adopting a supervised strategy. These methods usually rely on manual annotations that require a lot of time and effort from medical experts. In this study, we present a self-supervised approach for segmentation of nuclei for whole slide histopathology images. Our method works on the assumption that the size and texture of nuclei can determine the magnification at which a patch is extracted. We show that the identification of the magnification level for tiles can generate a preliminary self-supervision signal to locate nuclei. We further show that by appropriately constraining our model it is possible to retrieve meaningful segmentation maps as an auxiliary output to the primary magnification identification task. Our experiments show that with standard post-processing, our method can outperform other unsupervised nuclei segmentation approaches and report similar performance with supervised ones on the publicly available MoNuSeg dataset. Our code and models are available online to facilitate further research.
△ Less
Submitted 16 July, 2020;
originally announced July 2020.